Literature DB >> 12970260

Endocrine mechanisms of disease: Expression and degradation of androgen receptor: mechanism and clinical implication.

Dong Kun Lee1, Chawnshang Chang.   

Abstract

The androgen-androgen receptor (AR) signaling pathway plays a key role in proper development and function of male reproductive organs, such as prostate and epididymis, as well as nonreproductive organs, such as muscle, hair follicles, and brain. Abnormalities in the androgen-AR signaling pathway have been linked to diseases, such as male infertility, Kennedy's disease, and prostate cancer. Regulation of AR activity can be achieved in several different ways: modulation of AR gene expression, androgen binding to AR, AR nuclear translocation, AR protein stability, and AR trans-activation. This review covers mechanisms implicated in the control of AR protein expression and degradation, and their potential linkage to the androgen-related diseases. A better understanding of such mechanisms may help us to design more effective androgens and antiandrogens to battle androgen-related diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970260     DOI: 10.1210/jc.2003-030261

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  44 in total

1.  Characteristics of a human prostate stromal cell line related to its use in a stromal-epithelial coculture model for the study of cancer chemoprevention.

Authors:  Lena Diaw; Mark Roth; Debra A Schwinn; Mary E d'Alelio; Lisa J Green; Joseph A Tangrea
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

2.  Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.

Authors:  Rajeev Kumar; Vikas Verma; Amit Sarswat; J P Maikhuri; Ashish Jain; Rajeev K Jain; V L Sharma; Diwakar Dalela; Gopal Gupta
Journal:  Invest New Drugs       Date:  2010-12-23       Impact factor: 3.850

3.  Molecular Basis of Steroid Action in the Prostate.

Authors:  Yuan-Shan Zhu
Journal:  Cellscience       Date:  2005-04-28

4.  A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expression.

Authors:  Wei Qi; Hong Wu; Lin Yang; Douglas D Boyd; Zhengxin Wang
Journal:  EMBO J       Date:  2006-12-14       Impact factor: 11.598

5.  Androgen receptor overexpression is neuroprotective in experimental stroke.

Authors:  Patricia Ayala; Masayoshi Uchida; Kozaburo Akiyoshi; Jian Cheng; Joel Hashimoto; Taiping Jia; Oline K Ronnekleiv; Stephanie J Murphy; Kristine M Wiren; Patricia D Hurn
Journal:  Transl Stroke Res       Date:  2011-04-15       Impact factor: 6.829

6.  Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells.

Authors:  S Sarkar; D L Brautigan; S J Parsons; J M Larner
Journal:  Oncogene       Date:  2012-12-17       Impact factor: 9.867

7.  Bone mass and the CAG and GGN androgen receptor polymorphisms in young men.

Authors:  Amelia Guadalupe-Grau; Francisco Germán Rodríguez-González; Jesús Gustavo Ponce-González; Cecilia Dorado; Hugo Olmedillas; Teresa Fuentes; Jorge Pérez-Gómez; Joaquín Sanchís-Moysi; Bonifacio Nicolás Díaz-Chico; José A L Calbet
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

8.  [Sex hormones and dry eye].

Authors:  F Schirra; B Seitz; N Knop; E Knop
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

9.  Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expression.

Authors:  Dennis J van de Wijngaart; Hendrikus J Dubbink; Michel Molier; Carola de Vos; Jan Trapman; Guido Jenster
Journal:  Mol Endocrinol       Date:  2009-09-17

10.  Nuclear export signal of androgen receptor (NESAR) regulation of androgen receptor level in human prostate cell lines via ubiquitination and proteasome-dependent degradation.

Authors:  Yanqing Gong; Dan Wang; Javid A Dar; Prabhpreet Singh; Lara Graham; Weijun Liu; Junkui Ai; Zhongcheng Xin; Yinglu Guo; Zhou Wang
Journal:  Endocrinology       Date:  2012-10-05       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.